Indaptus Therapeutics INDP SEC Filings

NASDAQ INDP
$2.98 +0.02 (+0.85%)
As of: Oct 21, 2026 · 12:43 PM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Indaptus Therapeutics, Inc. (INDP) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
18-KCurrent Report0001493152-26-047770Oct 20, 2026 12:38 AM
2S-8Prospectus0001493152-26-045746Oct 5, 2026 4:05 PM
38-KCurrent Report0001493152-26-045040Sep 30, 2026 9:05 AM
48-KCurrent Report0001493152-26-042037Sep 10, 2026 1:45 AM
58-KCurrent Report0001493152-26-041636Sep 8, 2026 1:55 AM
68-KCurrent Report0001493152-26-041532Sep 4, 2026 8:05 PM
7424B5Prospectus0001493152-26-041526Sep 4, 2026 8:00 PM
88-KCurrent Report0001493152-26-040926Sep 1, 2026 7:30 AM-
9424B5Prospectus0001493152-26-040751Aug 31, 2026 1:25 PM
10424B3Prospectus0001493152-26-040246Aug 26, 2026 8:35 PM
11EFFECTOthers9999999995-26-002761Aug 25, 2026 4:15 AM
12S-3Prospectus0001493152-26-038780Aug 17, 2026 5:00 PM
1310-QQuarterly & Annual Report0001493152-26-037579Aug 13, 2026 7:35 AM
148-KCurrent Report0001493152-26-037574Aug 13, 2026 7:30 AM
15EFFECTOthers9999999995-26-002348Jul 17, 2026 4:15 AM
16DEF 14AOthers0001493152-26-033545Jul 16, 2026 8:35 PM
17SCHEDULE 13DBeneficial Ownership Report0001829126-26-006953Jun 26, 2026 1:40 AM
18SCHEDULE 13DBeneficial Ownership Report0001829126-26-006951Jun 26, 2026 12:00 AM
19SCHEDULE 13DBeneficial Ownership Report0001829126-26-006950Jun 26, 2026 12:00 AM
20SCHEDULE 13DBeneficial Ownership Report0001829126-26-006949Jun 26, 2026 12:00 AM
21S-3Prospectus0001493152-26-030346Jun 26, 2026 9:21 PM
228-KCurrent Report0001493152-26-029918Jun 24, 2026 8:01 PM
23PRE 14AOthers0001493152-26-029633Jun 22, 2026 9:25 PM
248-KCurrent Report0001493152-26-027499Jun 5, 2026 8:30 PM
2510-QQuarterly & Annual Report0001493152-26-023362May 15, 2026 12:15 PM
268-KCurrent Report0001493152-26-023344May 15, 2026 12:00 PM
27SCHEDULE 13DBeneficial Ownership Report0001829126-26-004104Apr 29, 2026 8:05 PM
28SCHEDULE 13DBeneficial Ownership Report0001829126-26-004104Apr 29, 2026 8:05 PM
29SCHEDULE 13DBeneficial Ownership Report0001829126-26-004104Apr 29, 2026 8:05 PM
308-KCurrent Report0001493152-26-018954Apr 24, 2026 9:00 PM
318-KCurrent Report0001493152-26-018608Apr 23, 2026 1:59 AM
323Insider Transaction0001829126-26-003665Apr 20, 2026 8:05 PM
333Insider Transaction0001829126-26-003665Apr 20, 2026 8:05 PM
343Insider Transaction0001829126-26-003665Apr 20, 2026 8:05 PM
35SCHEDULE 13GBeneficial Ownership Report0001104659-26-039973Apr 6, 2026 8:40 PM
368-KCurrent Report0001493152-26-015079Apr 3, 2026 4:00 PM
373Insider Transaction0001493152-26-015004Apr 2, 2026 11:18 PM
383Insider Transaction0001493152-26-015002Apr 2, 2026 11:16 PM
393Insider Transaction0001493152-26-015002Apr 2, 2026 11:16 PM
403Insider Transaction0001493152-26-015002Apr 2, 2026 11:16 PM
413Insider Transaction0001493152-26-015000Apr 2, 2026 11:15 PM
423Insider Transaction0001493152-26-015000Apr 2, 2026 11:15 PM
433Insider Transaction0001493152-26-015000Apr 2, 2026 11:15 PM
44SCHEDULE 13DBeneficial Ownership Report0001829126-26-002858Mar 30, 2026 1:46 AM
458-KCurrent Report0001493152-26-012372Mar 24, 2026 8:30 PM
46SCHEDULE 13DBeneficial Ownership Report0001829126-26-002642Mar 24, 2026 8:05 PM
474Insider Transaction0000921895-26-000788Mar 24, 2026 8:02 PM
4810-KQuarterly & Annual Report0001493152-26-010585Mar 17, 2026 8:30 PM
49SCHEDULE 13DBeneficial Ownership Report0001829126-26-001810Mar 2, 2026 10:20 PM
504Insider Transaction0001493152-26-008330Feb 27, 2026 9:06 PM
...

Indaptus Therapeutics, Inc. SEC Filings API

Pull Indaptus Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=INDP&formtype=10-K,10-Q&api_key=YOUR_API_KEY